NCT00872300View on ClinicalTrials.gov

PHA-739358 for the Treatment of Multiple Myeloma

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2010

Conditions
Multiple Myeloma
Interventions
DRUG

PHA-739358

Weekly IV infusion for 3 consecutive weeks in a 4-week cycle

Trial Locations (4)

44093

University Hospital Hôtel-Dieu, Nantes

59037

Hôpital Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille

60611

The Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago

85259

MAYO Clinic, Scottsdale

Sponsors
All Listed Sponsors
lead

Nerviano Medical Sciences

INDUSTRY

NCT00872300 - PHA-739358 for the Treatment of Multiple Myeloma | Biotech Hunter | Biotech Hunter